Señales en vivo de 688091.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 03:00):

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic...

Stats
Volumen de hoy	1.37M
Volumen promedio	1.71M
Capitalización de mercado	6.23B
EPS	CNY0.169 ( 2023-10-29 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	38.56
ATR14	CNY0.0360 (0.09%)

Volumen Correlación

Largo: 0.16 (neutral)

Corto: -0.61 (weak negative)

Signal:(53.345) Neutral

Shanghai Yizhong Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shanghai Yizhong Correlación - Moneda/Commodity

0.49
( neutral )

-0.08
( neutral )

0.00
( neutral )

0.47
( neutral )

-0.46
( neutral )

-0.65
( weak negative )

Shanghai Yizhong Finanzas

Annual	2023
Ingresos:	CNY358.64M
Beneficio Bruto:	CNY334.59M (93.29 %)
EPS:	CNY1.020

FY	2023
Ingresos:	CNY358.64M
Beneficio Bruto:	CNY334.59M (93.29 %)
EPS:	CNY1.020

FY	2022
Ingresos:	CNY235.96M
Beneficio Bruto:	CNY218.99M (92.81 %)
EPS:	CNY0.900

FY	2021
Ingresos:	CNY4.08M
Beneficio Bruto:	CNY3.78M (92.75 %)
EPS:	CNY-0.0512

Financial Reports:

No articles found.

Shanghai Yizhong

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. The company was founded in 2009 and is based in Shanghai, China.